Fort Washington Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Sell |
3,783
-124
| -3% | -$59.5K | 0.01% | 268 |
|
|
2026
Q1 | $1.92M | Sell |
3,907
-248
| -6% | -$135K | 0.01% | 271 |
|
|
2025
Q4 | $2.41M | Buy |
4,155
+38
| +0.9% | +$21.5K | 0.01% | 257 |
|
|
2025
Q3 | $2M | Sell |
4,117
-512
| -11% | -$238K | 0.01% | 255 |
|
|
2025
Q2 | $1.88M | Sell |
4,629
-382
| -8% | -$160K | 0.01% | 259 |
|
|
2025
Q1 | $2.49M | Sell |
5,011
-98
| -2% | -$53.1K | 0.02% | 243 |
|
|
2024
Q4 | $2.66M | Buy |
5,109
+507
| +11% | +$279K | 0.02% | 238 |
|
|
2024
Q3 | $2.85M | Buy |
4,602
+415
| +10% | +$246K | 0.02% | 237 |
|
|
2024
Q2 | $2.32M | Buy |
4,187
+292
| +7% | +$167K | 0.02% | 241 |
|
|
2024
Q1 | $2.26M | Buy |
3,895
+20
| +0.5% | +$11.2K | 0.01% | 251 |
|
|
2023
Q4 | $2.06M | Buy |
3,875
+1,005
| +35% | +$486K | 0.01% | 249 |
|
|
2023
Q3 | $1.45M | Buy |
2,870
+303
| +12% | +$161K | 0.01% | 251 |
|
|
2023
Q2 | $1.34M | Buy |
2,567
+210
| +9% | +$113K | 0.01% | 259 |
|
|
2023
Q1 | $1.36M | Buy |
2,357
+10
| +0.4% | +$5.64K | 0.01% | 255 |
|
|
2022
Q4 | $1.29M | Buy |
2,347
+3
| +0.1% | +$1.59K | 0.01% | 259 |
|
|
2022
Q3 | $1.19M | Sell |
2,344
-110
| -4% | -$61.6K | 0.01% | 269 |
|
|
2022
Q2 | $1.33M | Sell |
2,454
-57
| -2% | -$31.4K | 0.01% | 259 |
|
|
2022
Q1 | $1.48M | Sell |
2,511
-20
| -0.8% | -$11.5K | 0.01% | 279 |
|
|
2021
Q4 | $1.69M | Sell |
2,531
-44
| -2% | -$27.5K | 0.01% | 277 |
|
|
2021
Q3 | $1.47M | Sell |
2,575
-255
| -9% | -$140K | 0.01% | 284 |
|
|
2021
Q2 | $1.43M | Hold |
2,830
| – | – | 0.01% | 288 |
|
|
2021
Q1 | $1.29M | Hold |
2,830
| – | – | 0.01% | 289 |
|
|
2020
Q4 | $1.32M | Buy |
2,830
+350
| +14% | +$164K | 0.01% | 292 |
|
|
2020
Q3 | $1.09M | Sell |
2,480
-24
| -1% | -$9.91K | 0.01% | 302 |
|
|
2020
Q2 | $907K | Buy |
2,504
+130
| +5% | +$43.6K | 0.01% | 316 |
|
|
2020
Q1 | $673K | Buy |
2,374
+219
| +10% | +$69.1K | 0.01% | 307 |
|
|
2019
Q4 | $700K | Sell |
2,155
-47
| -2% | -$14.3K | 0.01% | 348 |
|
|
2019
Q3 | $641K | Hold |
2,202
| – | – | 0.01% | 367 |
|
|
2019
Q2 | $647K | Buy |
2,202
+10
| +0.5% | +$2.75K | 0.01% | 361 |
|
|
2019
Q1 | $600K | Sell |
2,192
-5,185
| -70% | -$1.29M | 0.01% | 371 |
|
|
2018
Q4 | $1.65M | Buy |
7,377
+870
| +13% | +$204K | 0.02% | 289 |
|
|
2018
Q3 | $1.59M | Sell |
6,507
-50
| -0.8% | -$11.5K | 0.02% | 317 |
|
|
2018
Q2 | $1.36M | Buy |
6,557
+60
| +0.9% | +$12.7K | 0.01% | 324 |
|
|
2018
Q1 | $1.34M | Buy |
6,497
+302
| +5% | +$63.4K | 0.01% | 344 |
|
|
2017
Q4 | $1.18M | Hold |
6,195
| – | – | 0.01% | 381 |
|
|
2017
Q3 | $1.17M | Sell |
6,195
-55
| -0.9% | -$9.96K | 0.02% | 292 |
|
|
2017
Q2 | $1.09M | Buy |
6,250
+23
| +0.4% | +$3.86K | 0.02% | 300 |
|
|
2017
Q1 | $956K | Sell |
6,227
-48
| -0.8% | -$7.34K | 0.02% | 317 |
|
|
2016
Q4 | $885K | Sell |
6,275
-450
| -7% | -$66.3K | 0.01% | 324 |
|
|
2016
Q3 | $1.07M | Hold |
6,725
| – | – | 0.02% | 261 |
|
|
2016
Q2 | $994K | Buy |
6,725
+50
| +0.7% | +$7.38K | 0.02% | 276 |
|
|
2016
Q1 | $945K | Buy |
+6,675
| New | +$895K | 0.02% | 291 |
|
|
2015
Q4 | – | Sell |
-9,660
| Closed | -$1.18M | – | 433 |
|
|
2015
Q3 | $1.18M | Sell |
9,660
-300
| -3% | -$39.1K | 0.02% | 264 |
|
|
2015
Q2 | $1.29M | Buy |
9,960
+100
| +1% | +$13K | 0.02% | 242 |
|
|
2015
Q1 | $1.32M | Hold |
9,860
| – | – | 0.03% | 242 |
|
|
2014
Q4 | $1.24M | Buy |
9,860
+110
| +1% | +$13.4K | 0.02% | 245 |
|
|
2014
Q3 | $1.19M | Buy |
9,750
+530
| +6% | +$64.4K | 0.02% | 252 |
|
|
2014
Q2 | $1.09M | Buy |
9,220
+2,400
| +35% | +$282K | 0.02% | 281 |
|
|
2014
Q1 | $820K | Buy |
6,820
+35
| +0.5% | +$4.16K | 0.02% | 282 |
|
|
2013
Q4 | $756K | Buy |
6,785
+980
| +17% | +$97.4K | 0.02% | 360 |
|
|
2013
Q3 | $535K | Hold |
5,805
| – | – | 0.01% | 356 |
|
|
2013
Q2 | $491K | Buy |
+5,805
| New | +$483K | 0.01% | 350 |
|
Other funds holding TMO
RG
ECSS
LT
ATO
Fort Washington Investment Advisors's TMO Position: Q2 2026 in Review
Fort Washington Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, selling an estimated $59.5K and leaving 3,783 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #268.
Fort Washington Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q3 2024. 1,002 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Fort Washington Investment Advisors held 3,783 shares of Thermo Fisher Scientific worth $1.9M as of Q2 2026.
- Fort Washington Investment Advisors sold 124 Thermo Fisher Scientific shares in Q2 2026, an estimated $59.5K.
- Thermo Fisher Scientific made up 0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #268 holding.
- Fort Washington Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Fort Washington Investment Advisors's Thermo Fisher Scientific position peaked at $2.85M in Q3 2024.
- 1,002 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.